Disparities in Lung Cancer Screening Eligibility Still Exist
FRIDAY, Jan. 22, 2021 -- Despite increases in lung cancer screening eligibility, gender, racial, and ethnic screening disparities may still persist, according to a study published online Jan. 12 in JAMA Network Open.
Thomas J. Reese, Pharm.D., Ph.D., from the University of Utah in Salt Lake City, and colleagues used data from the Behavioral Risk Factor Surveillance System (2017 to 2018) to identify adults (aged 50 to 80 years) with a smoking history in 19 states that used the optional lung cancer screening module. Change in eligibility among female, male, Black, Hispanic, and White participants (40,869 individuals) was examined before and after the U.S. Preventive Services Task Force revised eligibility criteria.
The researchers found that the revised criteria increased eligibility for men (29.4 to 38.3 percent), women (25.9 to 36.4 percent), White individuals (31.1 to 40.9 percent), Black individuals (16.3 to 28.8 percent), and Hispanic individuals (10.5 to 18.7 percent). However, the odds of eligibility were lower for women versus men (adjusted odds ratio, 0.88) and for Black (adjusted odds ratio, 0.43) and Hispanic populations (adjusted odds ratio, 0.70) versus Whites.
"These findings suggest that screening disparities may persist among women and racial/ethnic minority populations with the revised guideline," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Read this next
FRIDAY, March 5, 2021 -- Three main modes of transmission have been identified for giardiasis outbreaks in the United States in 2012 to 2017, although a single transmission mode...
FRIDAY, March 5, 2021 -- Cancer survivors have poorer ambulatory function, which is associated with increased mortality, according to a study published online March 4 in Cancer...
FRIDAY, March 5, 2021 -- Among heart failure patients, hospital readmission is frequent and often occurs in the early postdischarge period, according to a study published online...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.